Genes such as CHKA, CEPT1, PLA2G12A, and PLA2G4B were upregulated in treatment-sensitive and PD-1-high samples (Figure 3E (iii, iv)), suggesting that more active lipid metabolism in these samples may contribute to enhanced cancer therapeutic efficacy. The gene discussed is CEPT1; the disease is cancer.